Credited from: ALJAZEERA
Walmart has settled a lawsuit with the U.S. government, accused of unlawfully dispensing opioids at its pharmacies. The Department of Justice announced on Friday that the settlement addresses serious allegations regarding the company’s compliance with the Controlled Substances Act, although specific terms remain undisclosed, according to Reuters and CBS News.
The Justice Department's lawsuit, initiated in December 2020, accused Walmart of filling thousands of invalid prescriptions and failing to report suspicious drug orders, contributing significantly to the opioid epidemic. The agency noted that the death toll from opioid overdoses exceeded 900,000 from 1999 to 2023, highlighting the serious implications of prescription practices in U.S. communities, as reported by Al Jazeera and Reuters.
Walmart expressed its satisfaction with the resolution, stating, "We are pleased to resolve this matter and will continue supporting the exceptional work our pharmacists do every day to provide outstanding patient care," according to CBS News and Al Jazeera. The company emphasized that it had settled for an “immaterial” amount relative to its income, reported at $11.7 billion for the six months ending July 31.
In previous settlements related to the opioid crisis, Walmart agreed to pay $3.1 billion to resolve many lawsuits from state and local governments, and similar cases were settled by other pharmacy giants like CVS and Walgreens. The Justice Department's spokesperson emphasized their ongoing commitment to holding accountable those contributing to the opioid crisis, according to Reuters and CBS News.